Ampio Pharmaceuticals Inc (AMPE)
0.33
+0.08
(+31.47%)
USD |
OTCM |
May 01, 15:59
Ampio Pharmaceuticals Cash from Operations (Quarterly): -2.309M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.309M |
| September 30, 2023 | -0.555M |
| June 30, 2023 | -3.399M |
| March 31, 2023 | -2.301M |
| December 31, 2022 | -4.294M |
| September 30, 2022 | -5.943M |
| June 30, 2022 | -5.947M |
| March 31, 2022 | -4.944M |
| December 31, 2021 | -3.704M |
| September 30, 2021 | -3.91M |
| June 30, 2021 | -2.328M |
| March 31, 2021 | -4.147M |
| December 31, 2020 | -2.88M |
| September 30, 2020 | -2.706M |
| June 30, 2020 | -4.59M |
| March 31, 2020 | -4.553M |
| December 31, 2019 | -4.751M |
| September 30, 2019 | -4.738M |
| June 30, 2019 | -3.454M |
| March 31, 2019 | -2.44M |
| December 31, 2018 | -2.327M |
| September 30, 2018 | -3.210M |
| June 30, 2018 | -2.998M |
| March 31, 2018 | -3.604M |
| December 31, 2017 | -2.572M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.130M |
| June 30, 2017 | -3.086M |
| March 31, 2017 | -2.621M |
| December 31, 2016 | -2.581M |
| September 30, 2016 | -2.498M |
| June 30, 2016 | -4.663M |
| March 31, 2016 | -4.884M |
| December 31, 2015 | -7.766M |
| September 30, 2015 | -6.247M |
| June 30, 2015 | -5.425M |
| March 31, 2015 | -7.006M |
| December 31, 2014 | -5.765M |
| September 30, 2014 | -6.758M |
| June 30, 2014 | -9.734M |
| March 31, 2014 | -8.484M |
| December 31, 2013 | -5.005M |
| September 30, 2013 | -5.392M |
| June 30, 2013 | -5.130M |
| March 31, 2013 | -3.606M |
| December 31, 2012 | -2.598M |
| September 30, 2012 | -1.904M |
| June 30, 2012 | -2.106M |
| March 31, 2012 | -3.107M |
| December 31, 2011 | -4.133M |
| September 30, 2011 | -1.529M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.947M
Minimum
Jun 2022
-0.555M
Maximum
Sep 2023
-3.761M
Average
-3.91M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| Tivic Health Systems Inc | -1.774M |
| Oragenics Inc | -1.102M |
| Actinium Pharmaceuticals Inc | -7.49M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -8.564M |
| Free Cash Flow Per Share (Quarterly) | -2.789 |
| Free Cash Flow Yield | -3.30K% |